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The gut microbiota affects many important host functions, including the immune response 
and the nervous system1. However, while substantial progress has been made in growing 
diverse microorganisms of the microbiota2, 23–65% of species residing in the human gut 
remain uncultured3,4, which is an obstacle for understanding their biological roles. A likely 
reason for this unculturability is the absence of key growth factors in artificial media, which 
are provided by neighboring bacteria in situ5,6. In the present study, we used co-culture to 
isolate KLE1738, which required the presence of Bacteroides fragilis to grow. Bio-assay 
driven purification of B. fragilis supernatant led to the isolation of the growth factor, which, 
surprisingly, is the major inhibitory neurotransmitter γ-aminobutyric acid (GABA). GABA 
was the only tested nutrient that supported growth of KLE1738, and genome analysis 
supported a GABA-dependent metabolism. Using growth of KLE1738 as an indicator, we 
isolated a variety of GABA-producing bacteria, and found that Bacteroides ssp. produced 
large quantities of GABA. Genome based metabolic modeling of the human gut microbiota 
revealed multiple genera with the predicted capability to produce or consume GABA. 
Transcriptome analysis of human stool from healthy individuals showed that GABA 
producing pathways are actively expressed by Bacteroides, Parabacteroides, and Escherichia 
species. By coupling 16S rRNA sequencing with fMRI imaging in patients with Major 
Depressive Disorder (MDD), a disease associated with an altered GABAergic response, we 
found that relative abundance levels of fecal Bacteroides are negatively correlated with brain 
signatures associated with depression.
We previously identified quinones as growth factors for uncultured bacteria of the human 
microbiome6. In this study, we searched for previously undescribed growth factors. On a 
densely inoculated plate, some uncultured bacteria may be growing because they are in 
proximity to cultivable organisms producing growth factors. Using this rationale, a fecal 
sample from a healthy human donor was plated on Fastidious Anaerobic Agar supplemented 
with yeast extract (FAAy), and newly formed colonies were noted daily for a week. Late 
forming colonies (appearing after 4–7 days – “candidate dependent”) were diluted and 
spread on FAAy, and a heavy inoculum of a neighboring, early forming colony (appearing 
after1–3 days – “candidate helper”) was spotted (Fig. 1A). Given that E. coli induced the 
growth of all quinone-dependent organisms in our previous study6, candidate dependents 
were counter-screened against E. coli (Fig. 1B).
After screening approximately 200 colonies for the desired dependency phenotype, we 
identified a single isolate that failed to grow in the presence of E. coli, but grew on a plate 
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with B. fragilis. This isolate, KLE1738, required the presence of Bacteroides fragilis 
KLE1758 (100% similar by 16S rRNA sequence to Bacteroides fragilis ATCC 25852), for 
growth (Fig. 1C). KLE1738 is a Gram-positive bacterium of the Ruminococcaceae family, 
and is 93.4% similar to Flavonifractor plautii VPI 0310 [S1]7 as well as Intestinimonas 
butyriciproducens SRB-521–5-I(T)8 by 16S rRNA gene sequence, with its closest relative by 
genome sequence similarity being the uncultured Firmicutes bacterium CAG:114 (Fig. 1D). 
Its dissimilarity by 16S rRNA gene sequence to existing type strains suggests KLE1738 is 
the first representative of an unreported genus of bacteria, using recent guidelines for 
assigning taxonomy9. KLE1738 is found on the NIH Most Wanted list10, indicating it has 
not been cultured, although it is fairly prevalent in the human gut microbiome, being 
detectable in 6,001 of 31,451 (19.08%) of human gut metagenomes available in the 
Integrated Microbial Next Generation Sequencing database (16S similarity threshold >99%, 
with a minimum sequence length of 200bp)11. However, KLE1738 appears to be a relatively 
minor constituent of the microbiome, detectable at a relative abundance >1% in only 
60/31,451 human gut metagenomes (0.19%).
The supernatant of a 48-hour culture of B. fragilis KLE1758 grown in rich medium induced 
growth of KLE1738 (Supplemental Information Fig. 1A, control in 1B), enabling bioassay-
driven purification of the growth factor. The supernatant was solvent-partitioned with ethyl 
acetate, and the aqueous fraction induced growth of KLE1738. The aqueous fraction was 
then separated on an HP-20 column, and the most polar fraction induced growth of 
KLE1738 (Supplemental Information Fig. 1C, non-inducing fraction in 1D). This active 
fraction was then further fractionated by preparative HPLC, yielding a single active fraction. 
NMR analysis revealed that it contained 10 compounds including 6 common amino acids, 3 
carboxylic acids and gamma-aminobutyric acid (GABA) (Supplemental Information Fig. 2). 
While all compounds identified in the active fraction were tested, only GABA induced 
growth of KLE1738 (Supplemental Information Fig. 1E, medium without GABA in 1F).
The growth requirement of GABA a was surprising, since this suggested that KLE1738 was 
unable to grow on glucose or the numerous amino acids and other nutrients present in the 
rich medium. Precursors and breakdown products of GABA, and over 100 common carbon 
or nitrogen sources (including all standard amino acids) were tested for their ability to 
induce growth of KLE1738, but none were active (Supplemental Information Table 1). In 
addition to the rich FAAy medium, multiple commercially available and published growth 
media were tested -- including those shown to enable recovery of diverse gut bacteria, 
YCFAg2 and GMM12 -- but none were found to promote the growth of KLE1738 in the 
absence of exogenous GABA. Systematically excluding components of FAAy medium 
showed that KLE1738 grows on solid agar with only peptone and GABA (Supplemental 
Information Table 2). These results indicate that GABA is a required nutrient for KLE1738 
in the tested experimental conditions.
To gain insight into the unusual growth requirements of KLE1738, the genome was 
sequenced and annotated. The annotated draft genome of KLE1738 revealed an unusual 
profile – there were no apparent entry points into central metabolism for common sugars, 
amino acids, or other carbon sources. Bacteria use phosphotransferases to uptake a variety of 
sugars, such as glucose, fructose, and mannose. Uptake is coupled to phosphorylation by the 
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membrane transporter Enzyme II, the last component of a phosphorylation pathway: 
phosphoenolpyruvate – Enzyme I – Hpr – Enzyme II13. KLE1738 appears to lack Enzyme I. 
The fact that only one component of the phosphorylation pathway is missing suggests a 
recent loss of function. Similarly, KLE1738 is predicted to have a limited set of ABC 
transporters (Supplemental Information Table 3). This agrees with the inability of KLE1738 
to grow on the tested nutrients. The utilization of GABA for carbon and nitrogen by bacteria 
has been reported before, although not as a required nutrient. The GABA shunt serves as a 
pathway for its conversion into succinate, which then enters into the TCA cycle14. However, 
KLE1738 appears to lack succinate semialdehyde dehydrogenase, an essential enzyme of 
this pathway. An alternative ATP-generating pathway for GABA consumption was described 
for the environmental anaerobe Clostridium aminobutyricum15. KLE1738 has homologs of 
all enzymes of this pathway (Supplemental Information Fig. 3), with some enzymes present 
in multiple copies (Supplemental Information Table 4). Feeding KLE1738 with 13C, 15N 
labeled GABA allowed us to detect its metabolites, butyrate and acetate, as well as hexanoic 
acid, an intermediate of fatty-acid biosynthesis (Supplemental Information Fig. 4 and Fig. 
5A-D, 4E-H). No incorporation of the 15N label was found. These results suggest that 
GABA is a carbon and energy source for KLE1738.
For some species, including E. coli, Lactobacillus ssp., and Bifidobacterium ssp., GABA 
secretion has been reported to serve as an acid-resistance mechanism. Decarboxylation of 
glutamate is induced at a low pH and produces GABA, which is then exported from the cell 
in a protonated form, alkalinizing the cytoplasm14. While E. coli does not induce growth of 
KLE1738, a strain overexpressing glutamate decarboxylase in E. coli K12 does, comparably 
to B. fragilis KLE1758 (Supplemental Information Fig. 6A-D).
Bacteroides fragilis, the helper of KLE1738, is a common gut bacterium, but we found that 
similarly to E. coli, GABA production by Bacteroides fragilis is only observed at a low pH 
(≤5.5) (Supplemental Information Fig. 7). Apparently, Bacteroides fragilis growing on a 
Petri dish acidifies the medium enough to induce GABA production. We therefore sought to 
find gut microorganisms capable of producing GABA at a physiologically relevant pH for 
the human large intestine (pH 5.7 – 7.4)16.
The unique GABA-dependence of KLE1738 was exploited to identify additional GABA 
producers in a co-culture assay. Stool samples were mixed with molten FAAy agar, allowed 
to solidify, and KLE1738 was then spread on top of the medium. By looking for zones of 
KLE1738 growth, we were able to identify gut bacteria that produce GABA (Fig. 2A, B). In 
addition to Bacteroides species, representatives from the Parabacteroides, Eubacterium, and 
Bifidobacterium genera were identified as GABA producers in this assay (Fig. 2B). Of 
those, Bacteroides ssp. (and to a lesser extent Parabacteroides sp.) were found to produce 
GABA within the pH range of the human large intestines (Fig. 2B).
We next sought to profile the GABA modulating potential of the human gut microbiome in 
silico. All available bacterial genes encoding for GABA consumption and production were 
obtained from RAST17 and/or UniProt18. These sequences were then used as input for a 
bidirectional best hit analysis against genomes of known members of the gut microbiota, as 
evident by their presence in the fecal 16S rRNA data set of the American Gut Project – a 
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crowd sourced microbiome sequencing project with over 10,000 participants19. Genomes 
were scored as “producer” if they had at least one complete metabolic route for GABA 
production or a “consumer” if they had the GABA shunt or GABA transaminase and at least 
7/11 of the remaining enzymes of the KLE1738 pathway (the presence of 7/11 enzymes was 
chosen due to poor annotation of the remaining enzymes). Of 1,159 genomes analyzed 
(consisting of 919 species), we identified 105, 205, and 211 species harboring the genetic 
potential to only produce, only consume, or both produce and consume GABA, respectively 
(Fig. 2C; more detail in Supplemental Information Table 5). Due to its dissimilarly to type 
strains and unique growth requirements, we propose the name “Evtepia gabavorous” for 
KLE1738. It will be described in a future manuscript, using traditional description methods 
for bacteria20.
To complement this approach, we applied a more rigorous in silico constraint-based 
modeling method to survey the potential GABA consumption and/or production of the gut 
microbiota. This was performed using KBase, a database that contains metabolic models 
computationally derived from genome sequences of many microorganisms21. Of the 919 
species used in the above bi-directional analysis, 533 had models represented in KBase, and 
these were examined for their ability to produce GABA from known precursors – glutamate, 
arginine, putrescine, and ornithine – or consume GABA via the KLE1738 pathway or the 
GABA shunt. The analysis predicted that 97 organisms had the capability to produce 
GABA, mostly via glutamate decarboxylase (Supplemental Information Fig. 7). Of these, 
>25% belong either to the genera Bacteroides or Parabacteroides (Fig. 2D). For 
consumption, we identified 102 potential consumers of this neurotransmitter, with the 
majority belonging to the Pseudomonas, Acinetobacter, and Mycobacterium genera (Fig. 
2D). The number of GABA consumers is likely an underestimate, since the KLE1738 
GABA consumption is poorly annotated and thus not captured in KBase.
To validate activity of the genes of interest in humans, we surveyed an existing human 
transcriptome stool dataset22 for active expression of transcripts associated with the 
bottlenecks of bacterial GABA metabolism (glutamate decarboxylase, gamma-
aminobutyrate:alpha-ketoglutarate aminotransferase and succinate semialdehyde 
dehydrogenase). The RNAseq data was assembled using the Trinity platform23, and 
retrieved coding sequences were subjected to BLASTN (90% cutoff at 1e−5). No transcripts 
were identified for enzymes involved in GABA consumption (perhaps attributable to the 
depth of sequencing), but multiple hits were found for glutamate decarboxylase 
(Supplemental Information Table 6). These transcripts were successfully mapped to the 
nearest type strains of some of our GABA producing panel, suggesting Bacteroides and 
Parabacteroides species produce GABA in humans (Supplemental Information Table 7). 
Surprisingly, a set of transcripts also mapped to Escherichia coli (Supplemental Information 
Table 6). Given the pH restrictions for GABA production by E. coli in vitro14, this may 
indicate the presence of acidic microenvironments in the large intestine.
In germ-free mice, GABA levels have been reported to be significantly decreased both in the 
stool and the blood24 (but an older report showed no difference in GABA blood levels in 
germ-free and specific pathogen free rats25). Similarly, in specific pathogen free mice, fecal 
GABA levels can be modifiable by antibiotics26, suggesting that the microbiota may 
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contribute to circulating levels of GABA. This is of interest, because multiple diseases are 
associated with an altered GABAergic profile, such as depression27. Accordingly, we sought 
to explore whether Bacteroides, perhaps the major bacterial producers of GABA in the 
human gut, were associated with clinically diagnosed Major Depressive Disorder (MDD). 
To do this, stool from 23 patients with MDD was collected and analyzed by 16S rRNA 
sequencing using the American Gut protocols. Resting state fMRI was acquired within 3 
days of stool sample collection and scans were co-registered to MNI-space. To investigate 
the relationship between neural circuitry important in depression and fecal Bacteroides 
abundance we focused, a priori, on the left dorsolateral prefrontal cortex (DLPFC) and 
default mode network (DMN). Our choice of the left DLPFC was guided by the highly 
replicated finding that the left DLPFC is hypoactive in depression28. Similarly, the DMN is 
involved in self-referential processing29 and negative rumination in depression30. Functional 
connectivity is elevated both within the DMN and with other networks in depression31 and 
normalizes with treatment response32. We found an expansive region of the default mode 
network spanning the left anterior medial frontal cortex in which functional connectivity 
with the left DLPFC was inversely correlated with the relative abundance of fecal 
Bacteroides (Fig. 3A,B). This region of significance overlapped extensively with both the 
left medial prefrontal and left frontopolar cortex, regions highly interconnected to the limbic 
system and thought to be important in emotional reappraisal and reward processing33,34. 
This cluster was unique, and we found no clusters in which functional connectivity was 
positively correlated with the relative abundance of Bacteroides. We found no associations 
with KLE1738, perhaps due to its low abundance. Interestingly, a recent study of 40 healthy 
women found that levels of Bacteroides were associated with increased gray matter in the 
cerebellum, hippocampus, and frontal regions of the brain, and exhibited reduced levels of 
anxiety, distress, and irritability after looking at photos to evoke an emotional response35. 
Furthermore, a high fat diet has been shown to reduce GABA levels in the rat prefrontal 
cortex by about 40%, which was associated with reduced levels Bacteroides and depressive-
like behavior36. Nonetheless, our pilot cohort has limitations – the sample size was small 
and consequently we did not correct for medications (listed in Supplemental Information 
Table 8), and the sequencing data was not quantitative. As such, this cohort should be 
expanded, to further profile whether Bacteroides, or the GABA they may produce, are 
involved in affecting behaviors.
Notably, it has been reported that treatment of mice with the probiotic bacterium 
Lactobacillus rhamnosus JB-1 reduces stress and depression-like behavior in a vagus nerve-
dependent manner37. This was accompanied by changes in the expression of GABA 
receptors in several areas of the brain, including the amygdala and hippocampus37, and a 
later study showed elevated brain GABA in mice post-supplementation with JB-1 after four 
weeks38. While JB-1 was not explicitly tested for its ability to produce GABA, other L. 
rhamnosus strains have been shown to produce GABA around a pH of 3.6–5.239. Some 
Bifidobacterium have been shown to produce GABA40, and introduction of a GABA 
producing Bifidobacterium strain resulted in an improved visceral sensitivity in a rat model 
of pain41. Importantly, a recent human study found that fecal microbiome transplant from 
lean to obese individuals resulted in increased levels of GABA in the plasma42, showing 
manipulating the microbiome may alter GABA levels. Our findings, combined with these 
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reports, suggest microbial-derived GABA may influence the host, and are the first step in 
understanding the biology of this intriguing connection.
Methods
Human stool collection
For cultivation experiments, stool samples from an adult healthy human donor were 
collected using a stool collection vessel (Medline Industries). Within five minutes of 
collection, 1 gram of stool was resuspended in 9 mL of sterile 20% glycerol in PBS and 
homogenized for 30 seconds using a vortex. 1 mL aliquots of this mixture were loaded in 
cryotubes and stored at −80 °C. Stool samples for cultivation experiments were collected 
with informed consent following an IRB approved protocol at Northeastern University 
(IRB# 08–11-16).
For the Major Depressive Disorder cohort, study participants were provided with sterile 
plastic 4 oz specimen collection cups at their first visit. They were instructed to collect stool 
the day of or the night before their second visit depending on their ability to produce a 
sample to make sure no more than 24 hours pass between stool sample collection and 
processing. Study participants were instructed to keep their stool samples at room 
temperature until they bring it to their second visit. Once a sample was received by study 
personnel, it was processed within an hour. American Gut sample kits were shipped at room 
temperature the day of sample processing (the standard shipping protocol used for the 
American Gut). Two 1.5 ml screw top plastic tubes per sample were filled with stool and 
immediately frozen at −80C for future studies.
Cultivation of helper-uncultured pairs from human stool samples
All cultivation was performed in a Coy Anaerobic Vinyl chamber with an atmosphere of 5% 
hydrogen, 10% CO2, 85% nitrogen. Stool samples were thawed and serially diluted in PBS 
under anaerobic conditions and bead-spread (7–10 beads/plate) on 1X Fastidious Anaerobic 
Agar (Accumedia) plates with 2.5% yeast extract (FAAy). Plates were incubated at 37 °C 
anaerobically for one week, and each day appearance of colonies was tracked by spotting the 
outside of the plates with different color markers. At the end of the week, serial dilutions of 
late forming colonies (appearance after 4–7 days) were prepared in PBS and bead spread on 
FAAy plates. Nearby (< 2 cm), early forming colonies (appearance after 1–3 days) were then 
resuspended in PBS at a high density. Five μL of this suspension was spotted on plates with 
their respective spread-plated candidate dependent, incubated for up to one week in the 
chamber, and observed daily. Growth induction of the dependent organism around the 
spotted helper indicated a positive hit. Strain nomenclature – KLE = Kim Lewis; # = strain 
number)
Taxonomic assignment
PCR was performed for candidate dependents, helpers, and other isolates using the general 
bacterial primers 27F (5’-AGAGTTTGATCMTGGCTCAG-3’) and 1492R (5’-
GGTTACCTTGTTACGACTT-3’) to amplify the 16S rRNA gene. The PCR reaction 
mixture was 12.5 μL GoTaq Master Mix (Promega), 1 μL 10 μM 27F and 1492R primers 
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(Operon), 9.5 μL Nuclease Free Water (Promega), and 1 μL of a colony resuspended in 100 
μL sterilized distilled water. The amplification conditions were one cycle of 95 °C for 5 min; 
30 cycles of 95 °C for 30 s, 55 °C for 30 s, 72 °C for 90 s; and finally one cycle of 72 °C for 
7 min. Amplification of PCR reactions were confirmed using gel electrophoresis on a 0.8% 
agarose gel containing ethidium bromide. Successful PCRs were sequenced by Macrogen 
Corporation using the 27F and 1492R primers using the Applied Biosystems 3730×l DNA 
analyzer. Quality control for sequences was performed using DNA Baser 
(www.DnaBaser.com, version 4.36.0), in which ends were trimmed until there were more 
than 75% good bases (defined by having a QV score of higher than 25) in an 18 base 
window. Identification of phylogenetic neighbors and calculation of pairwise sequence 
similarity were done using the EZTaxon server (http://www.eztaxon.org). The phylogenic 
tree for KLE1738 was built using the Randomized Axelerated Maximum Likelihood 
(RAxML) method43 via PATRIC44 (version 3.5.23).
Identification of GABA as a growth factor for KLE1738
A single colony of Bacteroides fragilis KLE1758 was inoculated into Brain Heart Infusion 
Broth (Becton Dickinson) with 0.1% cysteine-HCL, 5.0 mg/mL yeast extract, and 15 mg/L 
hemin (BHIych) and incubated in the anaerobic chamber at 37 °C. The 48-hour B. fragilis 
KLE1758 culture was then filter sterilized using a 0.22 μm syringe filter unit and 200 μL of 
the supernatant was loaded in a Millicell Single Well Hanging Insert (pore size of 0.4 μm) 
and placed on top of a BHIych agar plate with bead-spread (7–10 beads/plate) KLE1738. 
Induction of KLE1738 growth was observed after 48 hours. For all induction experiments, 
cells of KLE1738 were taken from 48-hour cultures on solid BHIych plates with 1 mg/mL 
GABA, or from plates spotted with B. fragilis.
The supernatant of B. fragilis KLE1758 (1 L) was solvent-partitioned with ethyl acetate (3 × 
500 mL, each 3 hours) to yield ethyl acetate-soluble fraction and water residue, respectively. 
All extractions and fractionations of the supernatant were tested for KLE1738 induction by 
loading 200 μL into a Millicell Single Well Hanging Insert, as described above. The water 
residue part induced growth of KLE1738, which allowed the highly polar water fraction to 
be applied to a HP-20 column for further fractionation, yielding six fractions [A-F, A: water 
eluted fraction (2L); B: 20% MeOH eluted fraction (1L); C: 40% MeOH eluted fraction 
(1L); D: 60% MeOH eluted fraction (1L); E: 80% MeOH eluted fraction (1L); and F: 100% 
MeOH eluted fraction (2L)]. The most polar fraction (A) turned out to be the active fraction 
for inducing growth of KLE1738, and was consequently separated by HPLC using an 
Agilent 1100 series HPLC system (Agilent Technologies) equipped with a photo diode array 
detector. The active fraction A (3.8 g) was further fractionated by a preparative HPLC 
(phenyl-hexyl column, Phenomenex Luna, 250 × 21.2 mm, 5 μm) with a flow rate of 10 
mL/min using an isocratic solvent system of 1% aqueous acetonitrile for 30 min, then to 
100% acetonitrile in the next 6 min, and 100% acetonitrile for the next 7 min to give 14 
fractions [A1 – A14, A1 (3–5 min); A2 (5–8 min); A3 (8–10 min); A4 (10–13 min); A5 
(13–16 min); A6 (16–19 min); A7 (19–22 min); A8 (22–25 min); A9 (25–29 min); A10 (29–
33 min); A11 (33–36 min); A12 (36–38 min); A13 (38–40 min); and A14 (40–43 min)] 
according to HPLC chromatography analysis. Among these fractions, the fraction A2 
induced growth of KLE1738. The active fraction was directly applied to NMR analysis 
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including 1H, 13C, 1H-1H COSY, TOCSY, HSQC, and HMBC experiments to identify its 
constituents in the fraction. All NMR experiments were carried out on a Varian INOVA 600 
MHz NMR spectrometer equipped with an indirect detection probe.
Testing other compounds for induction of KLE1738
Multiple compounds were tested for the ability to induce the growth of KLE1738. Stocks of 
each compound (purchased from Sigma, excluding the ATCC Mineral and Vitamin mixes 
purchased from ATCC) were prepared dependent on solubility in water (compounds and 
tested concentrations are found in Supplemental Information Table 1). 5 μL of the stocks 
were then spotted on FAAy plates spread with KLE1738, and incubated in the anaerobic 
chamber at 37 °C for a week. Biolog plates were tested per manufacturer’s instructions 
(Biolog).
Media exclusion experiments
To facilitate media exclusion experiments, we prepared batches of Fastidious Anaerobic 
Agar (FAA) using the recipe from Accumedia (Lansing, MI): 23 g/L Bacto proteose peptone 
no. 3 (BD), 5 g/L sodium chloride (Sigma), 1g/L Difco soluble starch (BD), 0.4 g/L sodium 
bicarbonate (Sigma), 1 g/L glucose (Sigma), 1 g/L sodium pyruvate (Sigma), 0.5 g/L L-
cysteine HCl-H2O (Sigma), 0.25 g/L sodium pyrophosphate (Sigma), 1 g/L L-arginine 
(Sigma), 0.5 g/L sodium succinate (Sigma), 0.01 g/L hemin (Sigma), 0.001 g/L menadione 
(Sigma), 12 g/L agar (Sigma), and 1.0 mg/mL GABA (Sigma). We then prepared batches of 
this “Homemade” Fastidious Anaerobic Agar (HFAA) with individual or several 
components removed to test the nutritional requirements of KLE1738. All induction 
experiments were performed using 48-hour cultures of KLE1738 grown on FAAy agar with 
1.0 mg/mL GABA, and incubated anaerobically as described above.
Whole genome sequencing and annotation
DNA from cells of KLE1738 grown 48 hours anaerobically on FAAy plates with 1.0 mg/mL 
GABA was isolated for genome sequencing using the PowerSoil® DNA Isolation Kit (Mo 
Bio, San Diego, CA) according to manufacturer specifications, yielding ~5.0 μg of high 
quality DNA. Genomic sequencing and de novo assembly was performed by the Genomic 
Core at Tufts University in Boston, MA. The genome of KLE1738 was sequenced on an 
Illumina MiSeq using MiSeq V2 500 cycles chemistry with a paired-end 250 bases format. 
Briefly, 100 ng of genomic DNA was sheared on a Covaris M220 to an average fragment 
size of around 600 bases. Using the fragmented DNA as input, the sequencing library was 
prepared with Illumina TruSeq Nano DNA Sample Preparation Kit per the manufacturer 
instruction. Base calling and demultiplexing was performed on the raw data from the MiSeq 
using CASAVA and fastq files were generated. De novo assembly of the genome was 
performed using Edena V3.131028 with a customized parameter optimization pipeline. The 
best assembled genome, as assessed by the contig statistic, was reported. Assembly yielded 
68 contigs (n), with all contigs having a sequence length longer than 200 bases (n:200). 
There are 7 contigs with a larger value than the N50 (119748), and the minimal contig 
length is 355 (min). The N20, N50 and N80 are 33403, 119748 and 204670, respectively. 
The largest contig length (max) is 344080, and the estimated genome size is 2500009. The 
draft genome was annotated using the RAST server and the KAAS (KEGG Automatic 
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Annotation Server) analysis tool of the KEGG (Kyoto Encyclopedia of Genes and Genomes) 
database45, version 2.0.
Preparation of U-13C, 15N-GABA and 13C feeding experiments
Recombinant glutamate decarboxylase (GAD) was purified from an Escherichia coli strain 
harboring a his-tagged gadB from the ASKA library using the suggested protocol46. The 
His-tagged GadB enzyme was eluted off of a Ni-NTA column, and was further purified by 
dialysis in PBS at 4 °C for 5h, with a 2–10K MWCO filter. GadB was quantitated by UV 
(μ~85000 M−1cm−1) and diluted to give a concentration of 1.7 μg/ μL. The following 
protocol was followed to convert U-13C, 15N-Glu (Cambridge Isotope Laboratories) to 
U-13C, 15N-GABA. Stocks of pyridoxal-5’-phosphate (PLP, 10 mM, in water) and 
dithiothreitol (DTT, 1 mM, in water) were prepared fresh each experiment. In an Eppendorf 
tube, U-13C,15N-Glu (9.4 mg, 0.06 mmol 60 mM final) is dissolved in 0.2 M NaOAc buffer 
(750 μL, pH 4.6). To this is added 10 mM PLP (100 μL, 1 mM final), 1 mM DTT (100 μL, 
0.1 mM final), and 1.7 μg/ μL GAD (50 μL, 85 μg final). This is incubated in a 37 °C water 
bath for 18 h. The mixture is passed through a Ni-NTA column to remove protein, adjusted 
to pH 1 with 2 M HCl and lyophilized. This was repeated 4 times (~ 40 mg scale) to produce 
enough U-13C, 15N-GABA for analysis.
13C, 15N-GABA was fed to KLE1738 at a final concentration of 100 μg/mL on FAAy plates. 
After 72 hours of incubation in the anaerobic chamber, cells we resuspended in PBS, washed 
once, and pelleted. Agar was also collected. 13C metabolites were detected by MS (notably 
no 15N metabolites were identified). Bacteria were pelleted through centrifugation, the 
supernatant was discarded, and 2 M HCl (100 μL) was added. The sample was subsequently 
vortexed, H2O (Mill-Q, 500 μl) was added, the sample was vortexed again, and then was 
allowed to stand at room temperature for 10 min. Afterwards the sample was extracted with 
Et2O (3 × 2 mL), and the consolidated organic phase was dried with Na2SO4. The organic 
phase was then evaporated to dryness and the resulting material was resuspended in Et2O 
(500 μL). For extraction of the agar on which the bacteria was grown, the agar was sliced 
into small squares and 2 M HCl (10 mL) was added. The sample was vortexed, H2O (Mill-
Q, 50 mL) was then added, and the sample was vortexed again. The mixture was 
subsequently allowed to stand at room temperature for 10 min, and then was extracted with 
Et2O (3 × 50 mL). The consolidated organic phase was dried with Na2SO4, evaporated to 
dryness, and the resulting material was resuspended in Et2O (500 μL). The resuspended 
material was spun-down to pellet insoluble particulate, and the supernatant was passed 
through a 0.2 micron syringe filter to afford samples suitable for GC/MS analysis. All 
samples were analyzed on an Agilent 6890 GC with a Waters Quattro micro GC/MS/MS 
triple quadrupole mass spectrometer using electron ionization (EI) with a sample injection 
volume of 1 μL. A fused-silica capillary column of cross-linked DB-624UI (30 m x 0.32 mm 
ID, 1.80 μm film thickness, Agilent) was used. The GC conditions were as follows: inlet and 
transfer line temperate, 240 °C and 220 °C respectively; over temperature program, held at 
50 °C for 7 min, then increased to 250 °C at 50 °C/min, lastly held for 5 min; inlet helium 
carrier gas flow rate, 2.3 mL/min; split ratio: 30:1. The electron impact (EI)-MS conditions 
were as follows: ion source temperature, 200 °C; full scan m/z range 10–640 Da; selected 
ion recording (SIR) mode, m/z of 60 for monitoring of acetic and butyric acids. Data were 
Strandwitz et al. Page 10
Nat Microbiol. Author manuscript; available in PMC 2019 June 10.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
acquired and analyzed with Waters MassLynx V4.1 SCN805 software package and the NIST 
spectral library was used in searches to determine compound identities.
Quantification of GABA production
To measure the impact of pH on GABA production of KLE1758, triplicate cultures of B. 
fragilis KLE1758 were grown in 3 mL BHIych (pH 5.0, 5.5, 6.0 or 6.5) anaerobically for 48 
hours, the cells centrifuged, and the supernatant was filtered through a 0.2 μm filter. Samples 
were stored at 4°C until analysis (<48 hours). To analyze the samples, an aliquot (2 μL) of 
each sample was added to AccQ reaction buffer (16 μL), CSA internal standard (2 μL of a 
50 μg/mL solution in buffer), followed by the addition of the AccQ reagent (20 μL). These 
samples were heated to 55 °C for ten minutes, and then transferred directly into an LC/MS 
vial fitted with a glass insert. An aliquot of each sample (10 μL) was injected onto the 
LC/MS, and separated following the same injection program as used for the calibration 
curve. The total EIC area under curves representing GABA, Glu and CSA was determined 
using ChemStation software (Agilent). Each injection represented 25% of the original media 
concentration, therefore the total amount of sample determined (in ng) was multiplied by a 
factor of four to determine the original concentration (in ng/μL = μg/mL). All areas were 
normalized to the area under the curve of the internal standard (CSA), which was held at 
constant concentration throughout the experiment.
For quantification of GABA by strains identified in the co-culture screen with KLE1738, the 
above procedure was employed where one culture per strain was used instead, samples were 
stored at 4°C until analysis, and each prepared sample from a bacterial culture was run on 
the LC/MS twice. pH was measured using pH strips.
Co-culture screen for GABA producers using KLE1738
Molten FAAy was loaded into 50 mL centrifuge tubes and cycled into the anaerobic 
chamber. Diluted stool sample (from frozen stock) was mixed with the molten agar to reach 
a final dilution of 10−6 – 10−9 and 15 mL was plated in triplicate for each dilution. Once 
solidified, KLE1738 was resuspended in pre-reduced PBS (stored anaerobically for >24 
hours) and bead spread on top of the agar. Inoculated plates were incubated for one week, 
and growth of KLE1738 around colonies embedded in the agar indicated candidate GABA 
producing colonies. These candidate GABA producers were then restreaked on fresh FAAy 
and identified by 16S rRNA gene sequencing. All strains were confirmed to produce GABA 
on their respective mediums by co-culture with KLE1738 in isolation.
Co-culture of KLE1738 with E. coli overexpressing glutamate decarboxylase.
24 hour cultures of E. coli clones harboring native glutamate decarboxylases (gadA, gadB) 
or the GABA antiporter (gadC) in the pCA24N IPTG inducible high-copy number vector, 
were tested for GABA production via co-cultivation assay with KLE1738 on FAAy 
(described in Fig 1) with the addition of 1 mM IPTG. An E. coli clone harboring the empty 
vector and a 48 hour culture of B. fragilis KLE1758 growth in BHIYch served as a control. 
E. coli strains were taken from the ASKA library46.
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Metagenomic analysis of potential GABA producing or consuming bacteria
To identify potential GABA-producing and -consuming bacteria, a bidirectional best hit 
(BBH) nucleotide BLAST was performed. Operon nucleotide fasta sequences were retrieved 
from KBase (ftp://ftp.kbase.us/assets/KBase_Reference_Data/blast/fasta/kbase.ffn) and 
filtered for members of the gut microbiota by comparing 16S rRNA sequences that shared 
>99% sequence similarity to the healthy fecal set of organisms from the American Gut 
Project19. In total, sequences for 913 different gut bacteria were found in the KBase operon 
file (some species had multiple strain representatives, bringing the total analyzed genomes to 
1,159). To identify potential GABA consumers, genes involved in the KLE1738 GABA 
consumption pathway were downloaded from RAST45 and UniProt18. To identify organisms 
utilizing the GABA shunt, the list of GABA consumption genes was completed by adding 
all bacterial succinate semialdehyde dehydrogenase sequences found in UniProt. To identify 
potential GABA-producing organisms, nucleotide sequences for genes involved in the 
different pathways associated with GABA production (decarboxylation of glutamate, 
degradation of putrescine, or from arginine or ornithine) were downloaded from UniProt. 
The compiled lists of genes involved in GABA production or consumption were used as 
input for the BBH analysis against the gut microbe operon nucleotide sequences from 
KBase.
Metabolic modeling
In March 2016, all of the metabolic models from KBase, which were automatically 
generated in 2014 or earlier from all publicly available prokaryotic genome sequences, were 
downloaded. By comparing 16S rRNA sequences that shared >99% sequence similarity to 
the healthy fecal set of organisms from the American Gut project, 533 models were 
identified as gut-related (not all 913 microbes identified as gut related in Kbase have 
associated models). The models were forced to produce GABA (cpd00281) intracellularly 
([c]) by introducing the constraint “cpd00281[c] → “ and maximizing it, with all exchange 
reactions (except for GABA) allowed to be unbounded (−1000 to 1000). Reversing the 
GABA constraint revealed that no model can consume free GABA. To identify potential 
GABA consumers, the biochemical reactions involved in the KLE1738 GABA consumption 
pathway were defined, and models were examined for similar reactions. Specificity of 
cofactor molecules were not considered, only that GABA was being metabolized.
Transcriptomic analysis
We surveyed a published human stool transcriptome dataset22 to explore the activity of three 
major genes involved in GABA metabolism i.e. glutamate decarboxylase (gad), gamma-
aminobutyrate:alpha-ketoglutarate aminotransferase and succinate semialdehyde 
dehydrogenase in humans. The transcriptome data was assembled using Trinity23 which was 
further annotated for CDSs using prodigal47. BLASTN was used at % identity cut-off of 
75% and E-value of 1e-5 to retrieve active transcripts from the CDS-annotated transcriptome 
data using gene sequences. Five active transcripts were obtained for glutamate 
decarboxylase with lengths 519, 234, 231, 276 and 286 bp. This was additionally confirmed 
by mapping of raw transcriptome reads data on to the gene sequences which led to 
reconstruction of a 500 bp long gad transcript. Transcripts for gamma-aminobutyrate:alpha-
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ketoglutarate aminotransferase and succinate semialdehyde dehydrogenase could not be 
recovered from this data.
Major Depressive Disorder Cohort -- Subjects
23 currently depressed subjects between the ages of 19 and 65 (15 female) participated in 
the study. Subjects were recruited through referral from the outpatient clinic in the 
Department of Psychiatry at Weill Cornell Medical College. Subjects were also self-referred 
by directly contacting our mood disorders research program or from the local community via 
flyers, outreach at local events, or direct contact. The recruitment procedure and all other 
aspects of our experimental protocol were approved by the Institutional Review Board of 
Weill Cornell Medical College, and all experiments were conducted in accordance with 
institutional guidelines and regulations. Patients provided written informed consent.
All subjects participated in an initial screening interview to determine eligibility for 
enrollment in the study. Patients were eligible for inclusion if they met DSM-IV-Text 
Revision criteria for a major depressive episode with a diagnosis of major depressive 
disorder or bipolar II disorder and if they also met criteria for treatment resistance, including 
a failure to respond to at least two previous antidepressant trials at adequate doses for 8 
weeks during the current episode. Diagnoses were determined by a Board-Certified 
psychiatrist (MJD) in an unstructured clinical interview and through consultation with 
family members and the current treating psychiatrist. Potential subjects were excluded from 
the study if they presented with a history of claustrophobia, seizure disorder or other 
neurological disorder, head injury resulting in loss of consciousness, metal implants, 
pacemakers, intrauterine contraceptive devices, or braces, or if they were currently pregnant 
or lactating. Potential subjects were also excluded if they had bipolar I disorder or a 
psychotic disorder, were actively suicidal with plan or intent, had been in their current 
episode for longer than 3 years, had a history of clinically significant personality disorder as 
established in the diagnostic interview, or had substance abuse disorder or substance 
dependence within the past 3 years.
16S rRNA sequencing of the Major Depressive Disorder stool samples via the American 
Gut
Sequence data for the MDD patients in the American Gut dataset were produced in 
accordance with the standard Earth Microbiome Project 16S rRNA V4 amplicon sequencing 
protocol49. The MDD sequences analyzed corresponded to the set of samples represented by 
the April 26th 2017 processing. The American Gut sequences were processed using Deblur 
v1.0.250, and sequences corresponding to blooms were removed as previously reported51. 
Relative abundances of Bacteroides post-bloom filtering were used for the functional 
connectivity analysis.
Magnetic resonance imaging data acquisition and preprocessing
Magnetic resonance imaging data was collected on a 3.0 Tesla Siemens Trio MRI Scanner 
that was upgraded to a 3.0 Tesla Prisma MRI Scanner (Siemens, Munich, Germany) after the 
acquisition of imaging data from the first 10 subjects. Data were obtained from subjects in 
one session that occurred on or prior to the day of stool sample collection (mean=1.6d; 
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SD=3.6d). Each imaging session included a resting-state fMRI (rsfMRI) sequence (Trio 
Scanner: repetition time 2.25sec, 161 volumes; Prisma Scanner: repetition time 0.77sec, 425 
volumes) and a T1-weighted (MP-RAGE) anatomical scan. Preprocessing of rs-fMRI data 
was conducted with the AFNI (http://afni.nimh.nih.gov/afni/) and FSL (http://
www.fmrib.ox.ac.uk/fsl/) software packages and included motion correction (AFNI), spatial 
smoothing (6-mm full-width half-maximum Gaussian kernel; FSL), temporal band-pass 
filtering (0.005–0.1 Hz; AFNI), linear and quadratic detrending (AFNI), and removal of 
nuisance signals by regression on six motion parameters (roll, pitch, yaw, and translation in 
three dimensions) and signal time courses for white matter and cerebrospinal fluid (CSF) 
regions-of-interest (ROIs) determined on an individual basis using an automated 
segmentation algorithm (FSL). We did not use global signal regression52.
Regions of interest
The region of interest comprising the DMN was defined a priori based on previously 
published reports53. The left DLPFC seed was an ROI within BA46 (9 mm seed centered on 
MNI coordinates: –44, 40, 29)32.
Functional connectivity analysis
We first quantified functional connectivity between the left DLPFC and DMN areas by 
testing for correlations between the BOLD signal time series seeded from the left DLPFC 
with voxels in the DMN (see above). Next, to identify cortical clusters in the DMN in which 
left-DLPFC:DMN functional connectivity correlated with Bacteroides relative abundance, 
we performed an analysis of covariance (ANCOVA; implemented using AFNI’s 3dttest++ 
function), with age, gender, head motion, scanner (pre vs. post upgrade) and Bacteroides 
relative abundance as covariates. This generated a statistical map identifying areas of the 
DMN in which functional connectivity with the left DLPFC varied with Bacteroides relative 
abundance, controlling for the remaining covariates. Importantly, this analysis showed that 
the effects of relative Bacteroides abundance on left DLPFC:DMN functional connectivity 
were not driven by Bacteroides effects on head motion. This analysis also showed that 
effects of relative Bacteroides abundance on left DLPFC:DMN functional connectivity were 
indistinguishable in the groups of subjects scanned before and after the scanner upgrade. 
Next, a Monte Carlo simulation was performed for this map using AFNI’s 3dClustSim 
function to determine statistical thresholds for voxel cluster size needed to achieve a family-
wise α < 0.01 at voxel-wise p < 0.05. This yielded a threshold voxel cluster size of 213 
voxels. In addition, the spatial mean connectivity value (Z) of each significant cluster was 
extracted for each subject and a linear regression was performed for each cluster with 
Bacteroides relative abundance.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Co-culture assay to isolate KLE1738.
(A) Diluted human fecal sample was plated on Fastidious Anaerobe Agar with 0.5% yeast 
extract (FAAy), and slower growing, smaller colonies (formed after 4–7 days -- “candidate 
dependent”, example in blue box) were tested for dependence on their faster growing, larger 
neighboring colonies (formed after 1–3 days -- “candidate helper”, example in green box) by 
co-culture. (B) To identify growth factors, the candidate dependent was also tested for 
growth promotion with Escherichia coli BW25113. Using this method we isolated 
KLE1738, which grew around the helper (C) Bacteroides fragilis KLE1758, but not 
Escherichia coli (D). Experiments describing dependency phenotypes were repeated in 
triplicate. (E) Phylogenetic tree of closely related type and representative genomes 
belonging to the Ruminococcaceae family. Tree assembled using Randomized Axelerated 
Maximum Likelihood in PATRIC. Parts of Figure modified from Fenn, 20176; the culture 
plate and colonies highlighted in (A) is used for an illustration, and is not the source plate 
for KLE1738. A single stool sample yielded the KLE1738-KLE1758 helper-dependent pair.
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Fig. 2. In vitro and in silico identification of GABA modulating bacteria.
(A) To screen for GABA-producing bacteria, homogenized human stool sample was diluted 
and mixed with molten FAAy, with or without pH 7.0 MOPS buffer. KLE1738 was then 
spread on top of the agar and plates were incubated anaerobically for a week. Colonies that 
KLE1738 grew around were GABA producers (Inset). (B) Identified GABA producers were 
grown in liquid medium buffered at a pH of 5.0 and 7.0, and GABA levels of the spent 
medium was quantified using LC/MS and final pH of the medium was tested with pH strips. 
N=2 independent samples, and error is based on standard error. (C) 1,159 available gut 
genomes (consisting of 919 species) were analyzed for the genetic potential to produce 
and/or consume GABA (pathways associated with production or consumption highlighted in 
Supplemental Information Table 5). (D). The biochemical potential of 533 available gut-
related metabolic models in KBase were examined for the capability to produce GABA or 
consume GABA. Shown are genera that represent at least 0.5% of the 533 models and 
contain either GABA producers or consumers.
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Fig. 3. Fecal Bacteroides relative abundance inversely correlates with functional connectivity 
between left DLPFC and DMN structures in patients with Major Depressive Disorder (MDD).
(A) 3-Dimensional plots of the medial surface of the left and right hemispheres in patients 
with MDD (n=23). Significant cluster of 387 voxels in which fecal Bacteroides relative 
abundance correlated inversely with functional connectivity between this cluster and the left 
DLPFC. Colorbar shows Z scores of beta weights of the Bacteroides relative abundance 
covariate of a multiple linear regression with functional connectivity as the dependent 
variable. (B) Scatter plot of the average functional connectivity (Z score) over a sphere of 
radius 5mm centered at the voxel of peak significance (+12, −57, 0 in MNI coordinates) and 
abundance of fecal Bacteroides (Pearson r = −0.67, p=.0005). n=23.
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